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RESUMO
Introdução: O carcinoma da tiróide é raro em crianças e em adultos jovens. A maior parte das orientações clínicas baseia-se em 
dados obtidos na população adulta. Persistem diversas controvérsias no que se refere à agressividade da apresentação clínica e da 
abordagem terapêutica. 
Objectivo: Avaliar todos os doentes com carcinoma da tiróide com menos de 20 anos no momento da apresentação, reflectindo a 
experiência da nossa unidade relativamente ao diagnóstico, tratamento e seguimento desta entidade.
Material e Métodos: Trata-se de um estudo de revisão retrospectiva dos registos clínicos de todas as crianças e adultos jovens se-
guidos na Consulta de Oncologia do Serviço de Endocrinologia do Centro Hospitalar e Universitário de Coimbra entre 1996 e 2012 .
Resultados: Foram estudados 19 doentes, com uma média etária de 16 anos, sendo 13 do sexo feminino. Nenhum dos doentes fora 
previamente submetido a irradiação da região do pescoço. A queixa de apresentação era a presença de uma massa cervical palpável 
em 84,6% dos casos. Foi realizada citologia aspirativa em 15 doentes, que foi diagnóstica ou suspeita de neoplasia em 71,4% dos 
casos. A tiroidectomia total foi levada a cabo em 18 casos (94,7%). Em todos estes foi identificada a presença de um carcinoma papilar. 
A invasão vascular e multicêntrica ocorreu em 21,1% dos casos. A dimensão tumoral média foi de 2,5 cm. O envolvimento ganglionar 
cervical foi diagnosticado em 31,6% dos casos e a presença de metástases à distância foi identificada em 5,2% dos casos. Na maior 
parte dos doentes (18 em 19), o quadro foi classificado como doença em estadio I. Todos os doentes fizeram terapêutica supressora 
com tiroxina e 84,2% dos doentes foram submetidos a ablação pós-operatória com iodo radioactivo (dose média de 85,7mCi). Durante 
um seguimento médio de cerca de 6 anos, 16 doentes permaneceram em remissão.
Conclusão: Na nossa série, as taxas de metastização ganglionar cervical e à distância foram semelhantes às encontradas na popu-
lação adulta. O prognóstico foi globalmente muito satisfatório.
Palavras-chave: Neoplasias da Tiróide; Adolescente; Criança; Estudos Retrospectivos.
AbSTRACT
Introduction: Thyroid carcinoma is rare in children and young adults. Most of management guidelines are based in data from adult 
population. Several controversies remain regarding the aggressiveness of clinical presentation and therapeutic approach. 
Objective: To evaluate all differentiated thyroid carcinoma patients with less than 20 years-old at presentation reflecting the experience 
of our unit in relation to diagnosis, treatment and follow-up of this clinical entity.
Material and Methods: This is a retrospective review of clinical records of all children and young adults followed at Oncology Consulta-
tion of Department of Endocrinology of Centro Hospitalar e Universitário de Coimbra between 1996 and 2012. 
Results: Nineteen patients with mean age of 16 years old were followed, 13 girls and 6 boys. None of the patients had previous neck 
irradiation. A palpable cervical mass was the presenting complaint in 84.6%. FNA was performed in 15 patients and was diagnostic or 
suspicious of malignancy in 71.4%. Total thyroidectomy was performed in 18 cases (94.7%). Papillary carcinoma was identified in all. 
Vascular invasion and multicentry occurred in 21.1%. Mean tumor size was 2.5cm. Cervical lymph node involvement was diagnosed 
in 31.6% and distant metastases in 5.2%. The majority of patients (18 in 19) were classified as stage I disease. All patients received 
thyroxine suppressive therapy and postoperative radioiodine ablation was given to 84.2% (mean dose 85.7mCi). During mean follow-up 
of almost 6 years, 16 patients remain disease free.
Conclusion: In our series, cervical lymph node and distant metastases rates were similar to that found in adult population. Overall 
prognosis was very good. 
Keywords: Thyroid Neoplasms; Adolescent; Child; Retrospective Studies.
INTRODUCTION
 Thyroid carcinoma is rare in pediatric age, accounting 
for 1.5 to 3% of all childhood cancers in North America and 
Europe, but it´s incidence is increasing by 1.1% per year.1,2 
It’s very uncommon before age of 10 years, with an annual 
incidence of one per million, increases rapidly after adoles-
cence where it´s prevalence may reach 13%.2-5 Most thyroid 
nodules in children are benign and recent studies suggest 
that less than 1% are malignant.6 This is in contrast with 
older studies that report malignancy rates between 2 to 40% 
and likely represent ‘referral bias’ of children with increased 
risk factors for thyroid cancer.6 In this population more than 
90% of follicular cell-derived thyroid carcinomas are pa- 
pillary (PTC) and variants such follicular and diffuse sclero-
sing are frequent.4 Ionizing radiation remains the major risk 
factor for developing PTC but in most cases, specific risk 
factors cannot be identified.5,7 Familial history is also a risk 
factor in approximately 5% of children.8  Studies in younger 
have revealed differences in molecular biology of these 
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tumors.5,7 In children RET/PTC rearrangements have a high-
er prevalence.7 Particularly, RET/PTC3 is more common in 
patients with radiation-induced PTC and is associated with 
solid variant with short latency period and more aggressive 
clinical behavior.7 BRAF mutations are infrequent in chil-
dren with differentiated thyroid carcinoma.7 Also, metastatic 
focus in children expresses high levels of sodium-iodide 
transporter (NIS) which results in greater responsiveness 
to radioiodine treatment (RAI) and better prognosis.5 Treat-
ment options are similar between children and adults and 
are based in combination of three therapeutic modalities: 
surgery, hormone replacement with levothyroxine (LT4) 
and radiodine treatment. Controversies regarding the ideal 
therapeutic approach remain among the scientific commu-
nity and current recommendations and staging systems are 
based on data generated by studies on adults.5 Despite its 
aggressive presentation and higher recurrence rates, long 
term prognosis is excellent in this age group. As so, therapy 
should minimize treatment and disease related morbidity.9 
The aim of this retrospective study is to evaluate all differen-
tiated thyroid carcinoma patients with less than 20 years-old 
followed at Department of Endocrinology of Centro Hospita-
lar e Universitário de Coimbra (CHUC).
MATERIAL AND METHODS
 Nineteen patients with 20-years old or less were dia-
gnosed with DTC in our institution between 1996 and 2012. 
Patient’s health care records were reviewed to determine 
demographic data, clinical presentation, risk factors, family 
history, preoperative thyroid function, treatment interven-
tions and follow-up. Five patients were operated in other 
institutions and referred to our Department for follow-up 
after pathology result. Endocrinology department of CHUC 
has a highly differentiated thyroid oncology consultation. 
Tumor staging was performed based on the TNM (tumor-
node-metastases) tumor classification system9 and was 
assessed using data collected after thyroidectomy. Radioio-
dine ablative therapy was proposed to all patients, except if 
microcarcinoma. Ablation dose of 131I was calculated on an 
individual basis. Levothyroxine treatment was adjusted to 
suppression of TSH to less than 0.1mU/L. Follow-up of this 
patients include regular appointments for clinical evaluation 
and monitoring with thyroglobulin (Tg) assays and cervical 
ultrasonography (US). 
RESULTS
 Nineteen patients with age up to 20 years-old were 
identified: 13 girls and 6 boys, representing a ratio of 1:2.2 
male/female. Patients’ characteristics are resumed in Table 
1. The age of the patients at the time of the diagnosis of 
thyroid carcinoma ranged from 9 to 20 years (mean 16 ± 3.4 
years). Patients were followed during a mean period of six 
years. None of the patients had a history of head or neck ir-
radiation. Five patients had autoimmune thyroiditis medicat-
ed with levothyroxine. One patient´s mother had had papil-
lary thyroid carcinoma. A palpable cervical mass was the 
principal sign to call attention in twelve patients; a palpable 
adenomegaly was identified in two; in four patients the diag-
nosis was made incidentally during routine medical exam. No 
data available in one case. Sixteen patients had US results. 
Fourteen showed the presence of iso and hypoechogenic 
thyroid nodules, including three with microcalcifications and 
one with associated cervical adenopathy. One had goiter 
and cervical adenopathy, and another with diffuse increase 
in right lobe. Data concerning US results were missing in 
three cases. The nodule´s dimension ranged from 0.5 to 4.1 
cm (mean 2.3 cm). Results of fine needle aspiration (FNA) 
were available in sixteen patients (fourteen of thyroid nodule 
and two of suspicious cervical lymph node). Thyroid nodule 
FNA was diagnostic or suspicious of malignancy in 10 pa-
tients (71.4%), two (14.2%) had follicular tumor; a benign 
result (colloid) was identified in two of the patients (14.2%), 
in one of this cases FNA was repeated under US control. 
Lymph node FNA was positive for papillary thyroid carcino-
ma in one patient. Total thyroidectomy (TT) was performed 
in eighteen patients (94.7%). Seven patients were treated 
initially with lobectomy and six underwent a second surgical 
procedure after review of the final pathology result of initial 
procedure. Unilateral lymph node dissection was performed 
in seven patients. Four patients had postoperative tran-
sient hypocalcemia and one had simultaneously transient 
hoarseness. All cases corresponded to papillary thyroid car-
cinoma. The majority (57.9%) was classic. Three (15.8%) 
had follicular variant and two (10.5%) had microcarcinoma 
(tumor with less than 1cm). Rare variants were identified 
in three cases: diffuse sclerosing, solid growth pattern and 
Warthin like. Multicentry occurred in four patients (21.1%). 
Mean tumor size (n = 18) was 2.5cm (range 0.1 to 6.5 cm), 
with two (10.5%) microcarcinomas (tumor with less than 1 
cm). Vascular invasion was seen in four cases (21.1%) and 
thyroid capsular invasion in five (26.3%). Cervical lymph 
node metastases occurred in six patients (31.6%). Post-
operative radiodine ablation was given to sixteen patients 
(84.2%), in all unless microcarcinoma and if refused (case 
number 2) on average 3.4 months after surgery (in one only 
six years after). The initial amount of 131I that was adminis-
tered ranged from 60 to 126 mCi (mean 85.7). Post-thera-
peutic whole body scintigraphy was performed seven days 
after 131I, all patients presented with thyroid remnants, four 
with lymph node spread and one with pulmonary metas-
tases. All patients were submitted to levothyroxine therapy 
in suppressive doses. Six patients underwent additional 131I 
treatment (between one to four treatments). Mean cumula-
tive radiodiodine dose was 198mCi (range 60 to 874). Du-
ring mean follow-up of almost six years, 84.2% of patients 
remain free of disease. In one case (patient number 3) 
lymph node recurrence was detected after third radioiodine 
treatment but without suspicious images in last cervical US 
and thoracic TC, with Tg of 1.9 ng/dL under suppressive 
LT4. A girl (patient number 5) with disseminated pulmonary 
metastases was submitted to four 131I therapies during two 
and half years, with mean cumulative dose of 874 mCi, and 
also to upper left lung lobectomy. It was verified significa-
tive reduction of the number and dimension of pulmonary 
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lesions, with a progressive Tg reduction to 42 ng/dL under 
LT4 suppression. In last evaluation two patients (numbers 3 
and 12) had positive Tg with negative image. In this series, 
patients with rare and potential more aggressive histologi-
cal variants (cases 4 and 18) showed, so far, good clinical 
evolution with no recurrence (Table 1). 
DISCUSSION
 Differentiated thyroid carcinoma is an uncommon di-
sease in children and young adults. Most works agree that 
the clinical course of thyroid carcinoma in this age group is 
different than the clinical course in adults. Tumor volume 
tends to be larger in patients less than 20 years old and 
early involvement of thyroid capsule and surrounding tissue 
is seen, probably due to gland small volume.5 Multicentricity 
is also more frequent. Children present with more extensive 
disease, 40 to 90% present with lymph node involvement 
at diagnosis (compared to 20-50% of adults) and 20-30% 
with distant metastases, most commonly lung (versus 2% 
in adults).5,7 Although, Lazar et al verified that patients di-
agnosed after 1970 had less local invasion and lower in-
cidence of lymph node involvement and lung metastases, 
likely result of a precocity in diagnosis.10 But, despite chil-
dren present with more advanced stages of disease and 
higher recurrence rates, the overall prognosis is excellent. 
 Epidemiologic data in Portugal is missing. Two Portu-
guese centers found 2.3 and 2.2 cases/year in patients 
under 18 years old.11,12 In our institution during the last 16 
years we diagnosed and followed 19 young patients. The 
female to male ratio is in accordance to literature, that re-
fers prepubertal rates similar in boys and girls, after puberty 
ratio may reaches 2.5-6:1.4,7 We couldn´t find significant 
difference in clinical presentation between boys and girls. 
None of the patients had a history of head or neck irradia-
tion. In the majority (84.6%) the initial complaint was a pal-
pable cervical mass, the most common presentation form 
described.4,5,7 The evaluation of thyroid nodules in children 
remains controversial.13 Few centers have adequate experi-
ence to document the positive and negative predictive value 
of FNA for children but it seems to have a similar speci-
ficity and sensitivity as in adults.13 In this review, FNA of 
thyroid nodule was diagnostic or suspicious of malignancy 
in 71.4%. There were two cases of false negative values. 
In seven patients the initial surgical procedure was lobec-
tomy (mostly in cases where FNA findings were benign or 
follicular tumor), which lead to the necessity for a second 
intervention in six of them after pathology results. Some 
authors defend less aggressive management given the ex-
cellent prognosis of this disease and the risk of treatment 
morbidity.13 It seems that total or near total thyroidectomy 
reduces recurrence risk even in cases of unilateral and soli-
tary nodule with no regional or distant metastases or risk 
Table 1 - Summary of epidemiologic, clinical and pathological data of 19 children with PTC. 
Case 
nº Gender
Age 
(yr)
Tm 
size 
(cm)
Surgery TNM Metastatic spread Recurrence
131I 
Treatment
Follow-up 
duration 
(yr)
Additional 
information
1 F 16 0.1 L+I T1NxMx No No 0 6 AI T
2 F 11 1.2 TT+LND T1N0Mx No No 0 1 AI T
3 F 13 2.0 TT T1NxMx No Yes (LN) 3 8
4 F 13 3.6 TT+LND T3N1Mx LN No 1 1
Diffuse 
sclerosing 
variant
5 F 15 4.0 TT (2) T3NxM1 Pulmonar No 5 4
6 F 17 3.6 TT(2)+LND T2N1Mx LN No 2 4 Warthin like 
variant
7 F 10 a) TT+LND T4N1bMx LN No 3 13 AI T
8 F 15 1.8 TT(2) T1NxMx No No 1 1
9 F 16 5.0 TT+LND T3(m)N1Mx LN No 1 7
10 M 9 2.0 TT (2) T2NxMx No No 1 15
11 M 17 1.7 TT T3(m)NxMx No No 1 5
12 F 18 6.5 TT+LND T3N1M0 LN No 3 16
13 M 19 1.5 TT+LND T3(m)N1Mx LN No 2 8
14 F 19 1.2 TT T1NxMx No No 1 3 AI T
15 F 19 1.6 TT T1NxMx No No 1 3 AI T
16 M 16 3.9 TT (2) T2NxMx No No 1 1
17 M 20 0.8 TT T1NxMx No No 0 4
18 F 20 3.0 TT T2(m)NxMx No No 1 5 Solid
19 M 20 1.8 TT (2) T2NxMx No No 1 8
L+I – lobectomy+isthmectomy; TT – total thyroidectomy, (2) in two times; LND – lymph node dissection; LN - lymph node; AI T – autoimmune thyroiditis; a) no data available
Saraiva J, et al. Thyroid carcinoma in children and young adults: retrospective review, Acta Med Port 2013 Sep-Oct;26(5):578-582
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factors.7,10,13 The only patient in this series that didn´t com-
plete thyroidectomy had a papillary microcarcinoma with 
0.1 cm. Six year follow-up was negative for recurrence in 
this case. The value of lymph node dissection for children 
with PTC has not been well studied. Given the higher rate 
of lymph node dissemination in this population Rivkees et 
al recommend total or near total thyroidectomy along with 
central compartment lymph node dissection as part of the 
initial operation.7 Its not known if a correct preoperative US 
might detect this involvement limiting the value of node dis-
section.13 Latest ATA guidelines (2009) refer that, in adults, 
prophylactic central neck dissection may not be necessary 
in small (T1 or T2) non-invasive, clinically node-negative 
PTC9. In pediatric population this issue it´s not addressed. 
In the cohort presented, cervical dissection was performed 
in 7 patients and was positive in 6. This corresponds to a 
31.5% of cases of cervical lymph node metastasis at pre-
sentation. Also, we had only one case of distant metastasis 
(2.6%). This can be explained by the cohort median age, 
adding that almost all patients had more than 10 years-old. 
According to literature, age at presentation and extent di-
sease are the most significant prognostic factors for thyroid 
cancer.4 PTC is more aggressive when diagnosed before 
the age of 10 years. In older children and adolescents the 
initial extent of disease and outcome are similar to those 
observed in young adults.4 Radioiodine ablation was per-
formed in 84% of the patients. The use of radioactive iodine 
ablation for treatment of children with thyroid carcinoma re-
mains controversial. There are no randomized studies com-
paring RAI application versus no-RAI for remnant ablation 
in children, but there are several arguments in favor. Most 
authors recommend that most children should be treated 
with RAI to ablate residual disease and reduce the risk of 
disease recurrence.7 Good results were achieved in these 
patients with a mean dosage of 85.7mCi without reported 
adverse effects. An important component in therapy is thy-
roid hormone suppression with LT4 which is associated 
with reductions in the risk of growth or tumor proliferation 
induced by TSH. Baudin et al recommend initial suppres-
sion of TSH to less than 0.1mU/L followed by relaxation to 
0.5mU/L once patients enter remission, but bearing in mind 
that it may be difficult to enforce in pediatric population.7,14 
Risk assessment is very important component of DTC ma-
nagement. Actually AJCC/UICC is the most used system 
in several carcinomas, including thyroid. Patients under 45 
years of age are classified as stage I (any tumor, any lymph 
node, no metastasis) or II (any tumor, any lymph node with 
distant metastases). This may underestimate the malignant 
potential of these carcinomas in this population. Other prog-
nostic scoring systems may be useful in planning treatment 
for children, most of whom have AJCC stage 1 disease.5 
In this population 95% can be classified as stage 1 or low 
risk. Despite that, aggressive treatment strategies were em-
ployed in most of them (total thyroidectomy in 18, RAI in 
16 and suppressive LT4 therapy in all patients). These may 
have contributed to the overall good results in this cohort. 
The survival rate was 100% and, in last appointment, the 
majority of the patients were free of disease. This study has 
some limitations. First, this is a retrospective study with its 
associated difficulties in data collection resulting in miss-
ing information in some cases. Also, our hospital is an adult 
institution and not an oncologic unit which may explain the 
low annual incidence and the absence of very young chil-
dren. Despite this, and given the lack of clear international 
recommendations to guide management the authors think 
that´s important to report the experience accumulated and 
results achieved.
CONCLUSIONS
 Thyroid carcinoma is rare in children and young adults. 
This series, including 19 cases, has the advantage of a 
relatively long follow-up and several conclusions can be 
made. First, the 100% survival rate confirmed the over-
all good prognosis of DTC, similar to that in the literature. 
Second, and contrary to most of literature data, these pa-
tients showed initial rates of lymph node and distant metas-
tases similar to those of adult population (31.6% and 5.2%, 
respectively), not confirming the initial aggressive clinical 
presentation described in most studies. Finally, adequate 
initial treatment and long term follow-up were fundamental 
for good results achieved.
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